期刊文献+

鲑鱼降钙素在Caco-2细胞模型中的吸收机制 被引量:2

Absorption mechanism of salmon calcitonin by Caco-2 monolayer model
原文传递
导出
摘要 目的研究鲑鱼降钙素(SCT)在Caco-2细胞模型的吸收机制。方法采用人源结肠癌细胞系Caco-2细胞模型研究不同浓度SCT由绒毛面(AP侧)到基底面(BL侧)的转运过程,用HPLC法测定SCT在转运液中的浓度。结果 SCT 0.5~1.5 mg·m L-1对其表观渗透系数(Papp)无显著影响。结论 SCT在小肠上皮细胞主要以被动转运的方式吸收,有望将其开发成生物利用度较高的口服给药系统。 OBJECTIVE To study the absorption mechanism of salmon calcitonin by Caco- 2 monolayer model. METHODS A Caco- 2( the human colonic adenocarcinoma cell lines) cell monolayer had been applied to study the transport process of Salmon calcitonin from apical side( AP) to basolateral side( BL). The concentration in transfport medium buffer was performed by HPLC.RESULTS The results indicated that when SCT concentration between 0. 5 to1. 5 mg·m L- 1,there was no significant difference of apparent permeability coefficients( Papp). CONCLUSION The passive transference is the main intestinal absorption mechanism of salmon calcitonin in the Caco- 2 monolayer model. Salmon calcitonin is expected to develop a good oral delivery system.
出处 《华西药学杂志》 CAS CSCD 2016年第2期154-156,共3页 West China Journal of Pharmaceutical Sciences
基金 成都市企业自主创新项目(11GGY13529SW-289)
关键词 鲑鱼降钙素 CACO-2细胞模型 吸收机制 被动扩散 高效液相色谱法 Salmon calcitonin Caco-2 monolayer model Absorption mechanism Passive transport HPLC
  • 相关文献

参考文献8

  • 1M Azria. Possible mechanisms of the analgesic action of calcito- nin[J]. Bone,2002,30:80 - 83. 被引量:1
  • 2Hee Lee Y, Sinko PJ. Oral delivery of salmon calcitonin [J]. Ady Drug Delivery Rev ,2000,42:225 -238. 被引量:1
  • 3Yee S. In vitro permeability across Caco - 2 ceils ( clonic ) can predict in vivo( small intestinal) absorption in ,nan - fact or myth [ J]. Pharm Res, 1997,14 (6) :763 - 766. 被引量:1
  • 4Ingels F, Deferme S, Dstexhe E, et al. Simulated intestinal fluid as transport medium in the Caco - 2 cell culture model [ J ]. Int J Pharm,2002,232 ( 1- 2 ) : 183 - 192. 被引量:1
  • 5中华人民共和国国家药典委员会.中国药典[S].北京:中国医药科技出版社,2010:134. 被引量:162
  • 6马莲,杨秀伟.利用人源Caco-2细胞单层模型研究罂粟碱、N-甲基四氢罂粟碱和头花千金藤碱在人肠道的吸收[J].药学学报,2008,43(2):202-207. 被引量:9
  • 7Artursson P, Karlsson J. Correlation between oral drug absorption in human and apparent drug permeability coefficients in human intestinal epithelial ( Caco - 2 ) cells [ J ]. Bioehem Biophys Res Commun, 1991,175 (3) :880 - 885. 被引量:1
  • 8Hee Lee Y, Leesman GD, Makhey V, et al. Regional oral absorp- tion, hepatic first - pass effect, and non - linear disposition of salmon calcitonin in beagle dogs [ J ]. Eur J Pharm Biopharm, 2000,50(2) :205 - 211. 被引量:1

二级参考文献14

  • 1田莉,杨秀伟,王莹,徐嵬.顺式-和反式-阿霍烯在Caco-2细胞模型中的体外摄取、转运和外排特性[J].药学学报,2007,42(1):87-92. 被引量:7
  • 2杨秀伟.基于体内过程的中药毒性成分和毒性效应物质的发现策略[J].中华中医药杂志,2007,22(2):67-72. 被引量:34
  • 3杨秀伟.基于体内过程的中药有效成分和有效效应物质的发现策略[J].中国中药杂志,2007,32(5):365-370. 被引量:75
  • 4Yang XW..Absorption, Distribution, Metabolism, Excretion, Toxicity and Activity of the Chemical Constituents in Traditional Chinese Medicines ( 中药成分的吸收、分布、代谢、排泄、毒性与药效)[ M ]..Beijing:China Medico-Pharmaceutical Science Technology Publishing House,,2006..1449-1452,1458 - 1462.. 被引量:1
  • 5Yee SY. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal ) absorption in man-fact or myth [ J]. Pharm Res, 1997, 14:763 - 766. 被引量:1
  • 6Chong S, Dando SA, Morrison RA. Evaluation of biocoat intestinal epithelium differentiation environment (3-day cultured Caco-2 cells) as an absorption screening model with improved productivity [ J]. Pharm Res, 1997,14: 1835 - 1837. 被引量:1
  • 7Gao JN, Hugger ED, Beck-Westermeyer MS, et al.Estimating intestinal mucosal permeation of compounds using Caco - 2 cell monolayer [ M ]//Enna SJ. Current Protocols in Pharmacology. Chichester: John Wiley & Sons Inc. , 2000:7.2.1 -7.2.23. 被引量:1
  • 8Walle UK, French KL, Walgren RA, et al. Transport of genistein-7-glucoside by human intestinal Caco-2 cells: potential role for MRP2 [ J ]. Res Comm Mol Pathol Pharmacol, 1999,103:45 - 56. 被引量:1
  • 9Czarnecki W, Wielgus S. Effect of carriers and hydrophilic agents on papaverine spheres bioavailability [J]. Acta Pol Pharm, 1996,53:337 -340. 被引量:1
  • 10Kraus C, Shaaya A, Ulmer J, et al. Pharmacokinetics and bioavailability of papaverine HCl following intravenous, peroral, rectal, vaginal, topical and buccal administration in beagle dogs [ J ]. Biopharm Drug Dispos, 1991,12:537 -546. 被引量:1

共引文献169

同被引文献11

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部